Three-dimensional human skin models to understand Staphylococcus aureus skin colonization and infection

Frontiers in Immunology

Volumn 5, Issue FEB, 2014, Pages

  Popov, Lauren ^a   Kovalski, Joanna ^a   Grandi, Guido ^b   Bagnoli, Fabio ^b   Amieva, Manuel R ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NOVARTIS VACCINES AND DIAGNOSTICS   (Italy)

Author keywords

Colonization; MRSA; Organ culture; Skin; Staphylococcus aureus

Indexed keywords

ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GROWTH; BACTERIAL VIRULENCE; CELL DIFFERENTIATION; DERMIS; EPIDERMIS; FIBROBLAST; HUMAN; IMMUNE RESPONSE; KERATINOCYTE; NONHUMAN; PATHOGENESIS; SKIN APPENDAGE; SKIN CULTURE; SKIN INFECTION; STAPHYLOCOCCUS AUREUS;

EID: 84895521319     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2014.00041     Document Type: Article

References (60)

1. Mccaig LF, Mcdonald LC, Mandal S, Jernigan DB. Staphylococcus aureus-associated skin and soft tissue infections in ambulatory care. Emerg Infect Dis (2006) 12:1715-23. doi:10.3201/eid1211.060190.
2. Moran GJ, Amii RN, Abrahamian FM, Talan DAD. Methicillin-resistant Staphylococcus aureus in community-acquired skin infections. Emerg Infect Dis (2005) 11:928-30. doi:10.3201/eid1106.040641.
3. Eady EA, Cove JHJ. Staphylococcal resistance revisited: community-acquired methicillin resistant Staphylococcus aureus-an emerging problem for the management of skin and soft tissue infections. Curr Opin Infect Dis (2003) 16:103-24. doi:10.1097/00001432-200304000-00007.
4. Grice EA, Segre JAJ. The skin microbiome. Nat Rev Microbiol (2011) 9:244-53. doi:10.1038/nrmicro2537.
5. Kloos WE, Musselwhite MS. Distribution and persistence of Staphylococcus and Micrococcus species and other aerobic bacteria on human skin. Appl Environ Microbiol (1975) 30:381-95.
6. Kluytmans JJ, van Belkum AA, Verbrugh HH. Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev (1997) 10:505-20.
7. Eriksen NH, Espersen FF, Rosdahl VT, Jensen KK. Carriage of Staphylococcus aureus among 104 healthy persons during a 19-month period. Bull Entomol Res (1995) 115:51-60.
8. Noble WC, Valkenburg HA, Wolters CHC. Carriage of Staphylococcus aureus in random samples of a normal population. J Hyg (Lond) (1967) 65:567-73. doi:10.1017/S002217240004609X.
9. Peacock SJ, Justice AA, Griffiths DD, de Silva GD, Kantzanou MN, Crook DD, et al. Determinants of acquisition and carriage of Staphylococcus aureus in infancy. J Clin Microbiol (2003) 41:5718-25. doi:10.1128/JCM.41.12.5718-5725.2003.
10. Schechter-Perkins EM, Mitchell PM, Murray KA, Rubin-Smith JE, Weir S, Gupta K. Prevalence and predictors of nasal and extranasal staphylococcal colonization in patients presenting to the emergency department. Ann Emerg Med (2011) 57:492-9. doi:10.1016/j.annemergmed.2010.11.024.
11. Yang ES, Tan JJ, Eells SS, Rieg GG, Tagudar GG, Miller LGL. Body site colonization in patients with community-associated methicillin-resistant Staphylococcus aureus and other types of S. aureus skin infections. Clin Microbiol Infect (2010) 16:425-31. doi:10.1111/j.1469-0691.2009.02836.x.
12. Mckinnell JA, Huang SS, Eells SJ, Cui E. Quantifying the impact of extranasal testing of body sites for methicillin-resistant Staphylococcus aureus colonization at the time of hospital or intensive care unit admission. Infect Control Hosp Epidemiol (2013) 34(2):161-70. doi:10.1086/669095.
13. Wertheim HF, Vos MC, Ott AA, van Belkum AA, Voss AA, Kluytmans JA, et al. Risk and outcome of nosocomial Staphylococcus aureus bacteraemia in nasal carriers versus non-carriers. Lancet (2004) 364:3-3. doi:10.1016/S0140-6736(04)16897-9.
14. Wertheim HF, Melles DC, Vos MC, van Leeuwen W, van Belkum A, Verbrugh HA, et al. The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect Dis (2005) 5:751-62. doi:10.1016/S1473-3099(05)70295-4.
15. Smyth DS, Kafer JM, Wasserman GA, Velickovic LL, Mathema BB, Holzman RS, et al. Nasal carriage as a source of Agr-defective Staphylococcus aureus bacteremia. J Infect Dis (2012) 206:1168-77. doi:10.1093/infdis/jis483.
16. von Eiff CC, Becker KK, Machka KK, Stammer HH, Peters GG. Nasal carriage as a source of Staphylococcus aureus bacteremia. Study Group. N Engl J Med (2001) 344:11-6. doi:10.1056/NEJM200101043440102.
17. Krishna S, Miller LS. Host-pathogen interactions between the skin and Staphylococcus aureus. Curr Opin Microbiol (2012) 15:28-35. doi:10.1016/j.mib.2011.11.003.
18. O'Brien LM, Walsh EJ, Massey RC, Peacock SJ, Foster TJT. Staphylococcus aureus clumping factor B (ClfB) promotes adherence to human type I cytokeratin 10: implications for nasal colonization. Cell Microbiol (2002) 4:759-70. doi:10.1046/j.1462-5822.2002.00231.x.
19. Onunkwo CC, Hahn BL, Sohnle PG. Clearance of experimental cutaneous Staphylococcus aureus infections in mice. Arch Dermatol Res (2010) 302(5):375-82. doi:10.1007/s00403-010-1030-y.
20. Kanzaki H, Morishita Y, Akiyama H, Arata J. Adhesion of Staphylococcus aureus to horny layer: role of fibrinogen. J Dermatol Sci (1996) 12:132-9. doi:10.1016/0923-1811(95)00472-6.
21. Abe Y, Akiyama H, Arata J. Furuncle-like lesions in mouse experimental skin infections with Staphylococcus aureus. J Dermatol (1993) 20:198-202.
22. Kugelberg E, Norström T, Petersen TK, Duvold T, Andersson DI, Hughes D. Establishment of a superficial skin infection model in mice by using Staphylococcus aureus and Streptococcus pyogenes. Antimicrob Agents Chemother (2005) 49:3435-41. doi:10.1128/AAC.49.8.3435-3441.2005.
23. Prabhakara R, Foreman O, De Pascalis R, Lee GM, Plaut RD, Kim SY, et al. An epicutaneous model of community-acquired Staphylococcus aureus skin infections. Infect Immun (2013) 81(4):1306-15. doi:10.1128/IAI.01304-12.
24. Nippe N, Varga G, Holzinger D, Löffler B. Subcutaneous infection with S. aureus in mice reveals association of resistance with influx of neutrophils and Th2 response. J Invest Dermatol (2010) 131(1):125-32. doi:10.1038/jid.2010.282.
25. Cho JS, Zussman J, Donegan NP, Ramos RI, Garcia NC, Uslan DZ, et al. Noninvasive in vivo imaging to evaluate immune responses and antimicrobial therapy against Staphylococcus aureus and USA300 MRSA skin infections. J Invest Dermatol (2011) 131:907-15. doi:10.1038/jid.2010.417.
26. Kobayashi SD, Malachowa N, Whitney AR, Braughton KR, Gardner DJ, Long D, et al. Comparative analysis of USA300 virulence determinants in a rabbit model of skin and soft tissue infection. J Infect Dis (2011) 204:937-41. doi:10.1093/infdis/jir441.
27. Inoshima I, Inoshima N, Wilke GA, Powers ME, Frank KM, Wang Y, et al. A Staphylococcus aureus pore-forming toxin subverts the activity of ADAM10 to cause lethal infection in mice. Nat Med (2011) 17:1310-4. doi:10.1038/nm.2451.
28. Ridky TW, Chow JM, Wong DJ, Khavari PA. Invasive three-dimensional organotypic neoplasia from multiple normal human epithelia. Nat Med (2010) 16:1450-5. doi:10.1038/nm.2265.
29. Kretz MM, Siprashvili ZZ, Chu CC, Webster DE, Zehnder AA, Qu KK, et al. Control of somatic tissue differentiation by the long non-coding RNA TINCR. Nature (2013) 493:231-5. doi:10.1038/nature11661.
30. Auxenfans C, Fradette J, Lequeux C, Germain L, Kinikoglu B, Bechetoille N, et al. Evolution of three dimensional skin equivalent models reconstructed in vitro by tissue engineering. Eur J Dermatol (2009) 19:107-13. doi:10.1684/ejd.2008.0573.
31. Groeber F, Holeiter M, Hampel M, Hinderer S, Schenke-Layland K. Skin tissue engineering-in vivo and in vitro applications. Adv Drug Deliv Rev (2011) 63:352-66. doi:10.1016/j.addr.2011.01.005.
32. Lebonvallet N, Jeanmaire C, Danoux L, Sibille P, Pauly G, Misery L. The evolution and use of skin explants: potential and limitations for dermatological research. Eur J Dermatol (2010) 20:671-84. doi:10.1684/ejd.2010.1054.
33. de Breij A, Haisma EM, Rietveld M, Ghalbzouri El A, van den Broek PJ, Dijkshoorn L, et al. Three-dimensional human skin equivalent as a tool to study Acinetobacter baumannii colonization. Antimicrob Agents Chemother (2012) 56:2459-64. doi:10.1128/AAC.05975-11.
34. Hogk I, Rupp S, Burger-Kentischer A. 3D-tissue model for herpes simplex virus-1 infections. Methods Mol Biol (2013) 1064:239-51. doi:10.1007/978-1-62703-601-6_17.
35. Schaller M, Schackert C, Korting HC, Januschke E, Hube B. Invasion of Candida albicans correlates with expression of secreted aspartic proteinases during experimental infection of human epidermis. J Invest Dermatol (2000) 114:712-7. doi:10.1046/j.1523-1747.2000.00935.x.
36. Soong G, Chun J, Parker D, Prince A. Staphylococcus aureus activation of caspase 1/calpain signaling mediates invasion through human keratinocytes. J Infect Dis (2012) 205:1571-9. doi:10.1093/infdis/jis244.
37. Gangatirkar P, Paquet-Fifield S, Li A, Rossi R, Kaur P. Establishment of 3D organotypic cultures using human neonatal epidermal cells. Nat Protoc (2007) 2:178-86. doi:10.1038/nprot.2006.448.
38. Stark H-J, Szabowski A, Fusenig NE, Maas-Szabowski N. Organotypic cocultures as skin equivalents: a complex and sophisticated in vitro system. Biol Proced Online (2004) 6:55-60. doi:10.1251/bpo72.
39. Boelsma E, Verhoeven MC, Ponec M. Reconstruction of a human skin equivalent using a spontaneously transformed keratinocyte cell line (HaCaT). J Invest Dermatol (1999) 112:489-98. doi:10.1046/j.1523-1747.1999.00545.x.
40. Maas-Szabowski N. Epidermal tissue regeneration and stromal interaction in HaCaT cells is initiated by TGF. J Cell Sci (2003) 116:2937-48. doi:10.1242/jcs.00474.
41. Schoop VM, Mirancea N, Fusenig NE. Epidermal organization and differentiation of HaCaT keratinocytes in organotypic coculture with human dermal fibroblasts. J Invest Dermatol (1999) 112:343-53. doi:10.1046/j.1523-1747.1999.00524.x.
42. Holland DB, Bojar RA, Farrar MD, Holland KT. Differential innate immune responses of a living skin equivalent model colonized by Staphylococcus epidermidis or Staphylococcus aureus. FEMS Microbiol Lett (2009) 290:149-55. doi:10.1111/j.1574-6968.2008.01402.x.
43. Corriveau M-N, Zhang N, Holtappels G, Van Roy N, Bachert C. Detection of Staphylococcus aureus in nasal tissue with peptide nucleic acid-fluorescence in situ hybridization. Am J Rhinol Allergy (2009) 23:461-5. doi:10.2500/ajra.2009.23.3367.
44. Ohnemus U, Kohrmeyer K, Houdek P, Rohde H, Wladykowski E, Vidal S, et al. Regulation of epidermal tight-junctions (TJ) during infection with exfoliative toxin-negative Staphylococcus strains. J Invest Dermatol (2008) 128:906-16. doi:10.1038/sj.jid.5701070.
45. Mcgrath JA, Uitto J. The filaggrin story: novel insights into skin-barrier function and disease. Trends Mol Med (2008) 14:8-8. doi:10.1016/j.molmed.2007.10.006.
46. Hauser CC, Wuethrich BB, Matter LL, Wilhelm JA, Sonnabend WW, Schopfer KK. Staphylococcus aureus skin colonization in atopic dermatitis patients. Dermatologica (1985) 170:35-9. doi:10.1159/000249514.
47. Leung DY, Bieber T. Atopic dermatitis. Lancet (2003) 361:10-10. doi:10.1016/S0140-6736(03)12193-9.
48. Leyden JJ, Marples RR, Kligman AMA. Staphylococcus aureus in the lesions of atopic dermatitis. Br J Dermatol (1974) 90:525-30. doi:10.1111/j.1365-2133.1974.tb06447.x.
49. Mildner M, Jin J, Eckhart L, Kezic S, Gruber F, Barresi C, et al. Knockdown of filaggrin impairs diffusion barrier function and increases UV sensitivity in a human skin model. J Invest Dermatol (2010) 130:2286-94. doi:10.1038/jid.2010.115.
50. Amagai MM, Stanley JRJ. Desmoglein as a target in skin disease and beyond. J Invest Dermatol (2012) 132:776-84. doi:10.1038/jid.2011.390.
51. Bukowski MM, Wladyka BB, Dubin GG. Exfoliative toxins of Staphylococcus aureus. Toxins (Basel) (2010) 2:1148-65. doi:10.3390/toxins2051148.
52. Ganesh VK, Barbu EM, Deivanayagam CC, Le BB, Anderson AS, Matsuka YV, et al. Structural and biochemical characterization of Staphylococcus aureus clumping factor B/ligand interactions. J Biol Chem (2011) 286:25963-72. doi:10.1074/jbc.M110.217414.
53. Miajlovic HH, Loughman AA, Brennan MM, Cox DD, Foster TJT. Both complement-and fibrinogen-dependent mechanisms contribute to platelet aggregation mediated by Staphylococcus aureus clumping factor B. Infect Immun (2007) 75:3335-43. doi:10.1128/IAI.01993-06.
54. Walsh EJ, O'Brien LM, Liang XX, Hook MM, Foster TJT. Clumping factor B, a fibrinogen-binding MSCRAMM (microbial surface components recognizing adhesive matrix molecules) adhesin of Staphylococcus aureus, also binds to the tail region of type I cytokeratin 10. J Biol Chem (2004) 279:50691-9. doi:10.1074/jbc.M408713200.
55. Wilke GA, Wardenburg JB. Role of a disintegrin and metalloprotease 10 in Staphylococcus aureus alpha-hemolysin-mediated cellular injury. Proc Natl Acad Sci U S A (2010) 107:13473-8. doi:10.1073/pnas.1001815107.
56. Ouwehand K, Spiekstra SW, Waaijman T, Scheper RJ, de Gruijl TD, Gibbs S. Technical advance: Langerhans cells derived from a human cell line in a full-thickness skin equivalent undergo allergen-induced maturation and migration. J Leukoc Biol (2011) 90:1027-33. doi:10.1189/jlb.0610374.
57. Dezutter-Dambuyant C, Black A, Bechetoille N, Bouez C, Maréchal S, Auxenfans C, et al. Evolutive skin reconstructions: from the dermal collagen-glycosaminoglycan-chitosane substrate to an immunocompetent reconstructed skin. Biomed Mater Eng (2006) 16:S85-94.
58. Laubach V, Zöller N, Rossberg M, Görg K, Kippenberger S, Bereiter-Hahn J, et al. Integration of Langerhans-like cells into a human skin equivalent. Arch Dermatol Res (2010) 303:135-9. doi:10.1007/s00403-010-1092-x.
59. van Belkum AA. Staphylococcal colonization and infection: homeostasis versus disbalance of human (innate) immunity and bacterial virulence. Curr Opin Infect Dis (2006) 19:339-44. doi:10.1097/01.qco.0000235159.40184.61.
60. Quinn GA, Tarwater PM, Cole AM. Subversion of interleukin-1-mediated host defence by a nasal carrier strain of Staphylococcus aureus. Immunology (2009) 128:e222-9. doi:10.1111/j.1365-2567.2008.02952.x.